Igm Biosciences shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Igm Biosciences (IGMS) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Igm Biosciences
Tip: Access up to 7 years of quarterly data
All positions including Igm Biosciences held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Igm Biosciences by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $149k | 9.0k | 16.54 |
| 2023-03-31 | $78k | 5.7k | 13.74 |
| 2022-12-31 | $97k | 5.7k | 17.01 |
| 2022-09-30 | $130k | 5.7k | 22.80 |
| 2022-06-30 | $97k | 5.4k | 18.03 |
| 2021-12-31 | $98k | 3.3k | 29.33 |
| 2021-09-30 | $219k | 3.3k | 65.76 |
| 2021-06-30 | $277k | 3.3k | 83.20 |
| 2021-03-31 | $256k | 3.3k | 76.69 |
| 2020-12-31 | $294k | 3.3k | 88.29 |
| 2020-09-30 | $246k | 3.3k | 73.81 |
| 2020-06-30 | $243k | 3.3k | 72.91 |
| 2020-03-31 | $137k | 2.4k | 56.15 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors